SHENZHEN CHUXING TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 16
SHENZHEN CHUXING TECHNOLOGY CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ZIEWLUEA. The owner is based in SHENZHEN,GUANGDONG.
NO. 25,XINLONG VILLAGE,GANGTOU
MARKET,BANTIAN, STREET,LONGGANG DISTRICT
SHENZHEN,GUANGDONG , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN CHUXING TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SHENZHEN CHUXING TECHNOLOGY CO., LTD. have?
SHENZHEN CHUXING TECHNOLOGY CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does SHENZHEN CHUXING TECHNOLOGY CO., LTD. file in?
SHENZHEN CHUXING TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SHENZHEN CHUXING TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN CHUXING TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as ZIEWLUEA. These are among 1 currently registered trademark in the portfolio.
What is SHENZHEN CHUXING TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN CHUXING TECHNOLOGY CO., LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.